Etilefrine (International)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C01CA01
CAS registry number (Chemical Abstracts Service)
0000709-55-7
Chemical Formula
C10-H15-N-O2
Molecular Weight
181
Therapeutic Categories
Sympathomimetic agent
Antihypotensive agent
Chemical Name
Benzenemetanol, α-[(etylamino)metyl]-3-hydroxy-
Foreign Names
- Etilefrinum (Latin)
- Etilefrin (German)
- Étiléfrine (French)
- Etilefrina (Spanish)
Generic Names
- Etilefrina (OS: DCIT)
- Etilefrine (OS: BAN)
- Étiléfrine (OS: DCF)
- Aethyladrianol (IS)
- Etilefrine Hydrochloride (OS: BANM, JAN)
- Etiléfrine (chlorhydrae d') (PH: Ph. Eur. 9)
- Etilefrine Hydrochloride (PH: BP 2018, JP XVII)
- Etilefrine hydrochloride (PH: Ph. Eur. 9)
- Etilefrinhydrochlorid (PH: Ph. Eur. 9)
- Etilefrini hydrochloridum (PH: Ph. Eur. 9)
Brand Names
- Balkis [+ Chlorphenamine]
Eipico, Egypt - Effortil
Boehringer, Peru; Boehringer Ingelheim, Egypt; Boehringer Ingelheim, Tunisia; Sanolabor, Slovenia - Etilefrina Larjan
Veinfar, Paraguay - Etrifin
AC Farma, Peru - Hyposia
Asian Pharm, Thailand - Menegradil
Fada, Uruguay - Tonnary
Maver, Mexico - Vascon
hi pharm, Egypt - Vasopress
Ceci Farma, Peru - Bioflutin
Südmedica, Germany - Buracard
Burapha, Thailand - Cinbinin
Swiss Pharm, Taiwan - Effontil
Boehringer Ingelheim, Venezuela - Effortil
Boehringer Ing., Paraguay; Boehringer Ingelheim, Belgium; Boehringer Ingelheim, Colombia; Boehringer Ingelheim, Costa Rica; Boehringer Ingelheim, Germany; Boehringer Ingelheim, Dominican Republic; Boehringer Ingelheim, France; Boehringer Ingelheim, Guatemala; Boehringer Ingelheim, Honduras; Boehringer Ingelheim, Italy; Boehringer Ingelheim, Luxembourg; Boehringer Ingelheim, Mexico; Boehringer Ingelheim, Nicaragua; Boehringer Ingelheim, Panama; Boehringer Ingelheim, Poland; Boehringer Ingelheim, Sweden; Boehringer Ingelheim, El Salvador; Boehringer Ingelheim, Uruguay; Boehringer Ingelheim, South Africa; IFET, Greece; Sanofi, Japan; Sanofi Oy, Finland; Sanofi-Aventis, Austria; Unilfarma, Portugal - Effortil 7,5 mg/ml
Sanofi-Aventis, Austria - Effortil 7.5mg/g
Sanofi-Aventis, Switzerland - Efortil
Boehringer Ingelheim España, Spain - Etilefril
União Química, Brazil - Etilefrina Clorhidrato Lasca
Lasca, Paraguay - Etilefrina Larjan
Larjan, Uruguay - Étiléfrine Serb
SERB Laboratoires, France - Fortinil
Novophar, Paraguay - Fortinil Retard
Novophar, Paraguay
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions:International Nonproprietary Names.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.